Eltrombopag-Mepha 25 mg

Eltrombopag-Mepha 25 mg is a medicine authorised by Swissmedic under authorisation number 69843. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 17 July 2025 and the authorisation is limited until 16 July 2030. ATC code B02BX05 places the medicine in the group Antihemorrhagics.

  • Dispensing category A
  • Authorisation number 69843
  • ATC B02BX05
  • Synthetic medicines
Authorisation data
Authorisation number69843
NameEltrombopag-Mepha 25 mg
Full nameEltrombopag-Mepha 25 mg, Filmtabletten
Authorisation holderMepha Pharma AG
Medicinal product codeSynthetic medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeB02BX05
First authorisation17 July 2025
Authorisation validity16 July 2030
Strengths
No.NameDispensing categoryAuthorisation date
1Eltrombopag-Mepha 25 mg, FilmtablettenA17 July 2025
2Eltrombopag-Mepha 50 mg, FilmtablettenA17 July 2025
3Eltrombopag-Mepha 75 mg, FilmtablettenA17 July 2025

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
114Tablette(n)B02BX0506.99.0.A
228Tablette(n)B02BX0506.99.0.A
314Tablette(n)B02BX0506.99.0.A
428Tablette(n)B02BX0506.99.0.A
528Tablette(n)B02BX0506.99.0.A

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Eltrombopag-Mepha 25 mg authorised in Switzerland?

Yes. Eltrombopag-Mepha 25 mg is authorised by Swissmedic under authorisation number 69843, data as of 01 September 2026. The authorisation is limited until 16 July 2030.

Which dispensing category does Eltrombopag-Mepha 25 mg have?

Eltrombopag-Mepha 25 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Eltrombopag-Mepha 25 mg?

The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com